跳至主要内容
临床试验/CTRI/2025/03/081561
CTRI/2025/03/081561尚未招募3 期

A randomised controlled trial comparinganaesthetic efficacy of 0.5 percentage Bupivacaine and0.5 percentage Levobupivacaine in supra-clavicularbrachial plexus block with peripheral nervestimulator in upper limb surgeries.

Manisha1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月3日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. Onset and duration of Sensory block

研究概览

简要总结

This study has been planned with an aim to compare the effectiveness of bupivacaine and levobupivacaine in supraclavicular brachial plexus block and to compare onset and duration of sensory ,motor blockade,duration of analgesia and hemodynamic parameters among patients undergoing upper limb surgeries.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients of either sex, aged 18–60 years, belonging to American Society of Anesthesiologists(ASA) physical status class I and II willing to participate in the study.

排除标准

  • Who refuses to give consent.
  • With severe cardiac, renal, endocrine, pulmonary disease.
  • Who are allergic to study drugs.
  • Who is having a local site infection.
  • With hemi-diaphragmatic paralysis on opposite side of surgery
  • With any psychological disorder who would interfere with assessment of pain.
  • With a history of brachial plexus injury.
  • With bilateral upper limb surgery and fracture.

结局指标

主要结局

1. Onset and duration of Sensory block

时间窗: Onset of sensory and motor blockade will be monitored every two minutes for the first 20 | minutes and then every five minutes till 30 minutes.

2. Onset and duration of motor block

时间窗: Onset of sensory and motor blockade will be monitored every two minutes for the first 20 | minutes and then every five minutes till 30 minutes.

次要结局

  • 1. Hemodynamic parameters including HR, SBP, DBP(2. Complications include hypotension, bradycardia, pneumothorax,nausea, vomiting and)

研究者

发起方
Manisha
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验